幼児期および青春期においてがん治療を受けた人々の長期的ケア
Emily S Tonorezos1, Richard J Cohn2, Adam W Glaser3
1Office of Cancer Survivorship, Division of Cancer Control and Population Sciences, National Cancer Institute, Rockville, MD, USA.
Lancet (London, England)
|April 17, 2022
まとめ
幼児の癌の生存者は 長期的な健康リスクと 介護の移行の課題に直面します 生存者の成果を改善するには,知識の欠陥を解決し,遅発の副作用に対するケア調整を強化する必要があります.
科学分野:
- 腫瘍学
- 遺族 の 介護
背景:
- 小児がん治療の進歩により 大人の生存者数が増加しました
- この増加する人口は 遅発した健康問題や 早期死亡のリスクが高くなります
- 障壁には,提供者/生存者の知識のギャップと分散した介護の移行が含まれます.
研究 の 目的:
- 子供や青年の癌の成人の生存者の健康リスクとケア課題を強調する.
- 成人の医療への移行期間におけるケア調整と支援の改善の必要性を強調する.
- 長期介護の管理に役立つリソースを特定する.
主な方法:
- 癌治療の遅発性効果に関する既存の文献のレビュー
- 小児がんの生存者を成人の介護施設に移すための課題の分析
- 生存者の介護のためのベストプラクティスとリソースの特定
主要な成果:
- 幼児がんの生存者は,様々な遅発の副作用 (心臓,内分泌,肺,生殖力,腎臓,心理,認知,社会発達) に敏感です.
- 介護の調整と成人の介護への移行は大きな課題です.
- 効果的なコミュニケーションと自己管理のサポートは 生存者に力を与え 成果を上げることができます
結論:
- 小児がんの成人の生存者は,治療の遅い効果のために専門的な継続的な監視を必要とします.
- 長期的な健康管理には 成人ケアへの円滑な移行が不可欠です
- 監視ガイドラインやウェブベースのサポートのようなリソースは 提供者や生存者にとって不可欠です
関連する概念動画
02:56Treatment Resistant Cancers
3.4K
Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
3.4K
01:19Restorative Care
2.1K
Restorative care is provided once a patient has been discharged from a healthcare facility and requires additional services. The additional services include home care, rehabilitation programs, and extended care. Restorative care centers help the patient regain their previous level of functioning or acquire a new level of functioning due to the incapacitating effects of a disease or a disability. It aims to assist patients in enhancing their quality of life by encouraging independence,...
2.1K
01:25Continuing Care
1.6K
Continuing care describes the variety of health, personal, and social services provided over a prolonged period. The need for continuing care is increasing because people are living longer. Many people do not have families or others to care for them. Continuing care is mainly for patients who are disabled, functionally dependent, or suffering from a terminal disease. It is available within institutional settings or in homes. Examples include nursing centers or facilities, assisted living,...
1.6K
02:49Cancer Therapies
8.0K
Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
8.0K
02:20Longitudinal Research
12.6K
Sometimes we want to see how people change over time, as in studies of human development and lifespan. When we test the same group of individuals repeatedly over an extended period of time, we are conducting longitudinal research. Longitudinal research is a research design in which data-gathering is administered repeatedly over an extended period of time. For example, we may survey a group of individuals about their dietary habits at age 20, retest them a decade later at age 30, and then again...
12.6K
01:21Cancer Survival Analysis
472
Cancer survival analysis focuses on quantifying and interpreting the time from a key starting point, such as diagnosis or the initiation of treatment, to a specific endpoint, such as remission or death. This analysis provides critical insights into treatment effectiveness and factors that influence patient outcomes, helping to shape clinical decisions and guide prognostic evaluations. A cornerstone of oncology research, survival analysis tackles the challenges of skewed, non-normally...
472